Investing Profile

Andrew Bayliffe

InvestorVC
Venture Partner at Apple Tree Partners
appletreepartners.com/teamLondon
Photo of Andrew Bayliffe, ATP (Apple Tree Partners)
Your Intro Paths to Andrew Bayliffe
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Andrew Bayliffe on

cb
Current Investing Position
ATP (Apple Tree Partners)
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M

Andrew Bayliffe is on these Sector & Stage Rankings

Andrew Bayliffe's Experience

Chief Scientific Officer Marengo Therapeutics2020 - Present
Venture Partner Apple Tree Partners2019 - Present
Head, Respiratory and Inflammation Research Unit GSK2015 - 2020
Global Development Leader - Respiratory & Inflammation GSK2013 - 2015
Head, Translational Medicine - Biopharmaceuticals Innovation Unit GSK2011 - 2013
Clinical Pharmacology Leader - Biopharmaceuticals R&D GSK2008 - 2011
Clinical Pharmacology Leader - Immunology & Inflammation R&D GSK2004 - 2008
Translational Scientist - Clinical Pharmacology & Experimental Medicine GSK2002 - 2004
Research Scientist, Pharmacogenetics & Applied Diagnostics GSK2000 - 2002
Research Scientist AstraZeneca1998 - 2000

Andrew Bayliffe's Education

University of Leeds Doctor of Philosophy - PhD Pharmacology and Molecular Biology
The Manchester Metropolitan University Bachelor of Science - BS Pharmacology